LGND
USDLigand Pharmaceuticals Incorporated Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$188.200
High
$191.455
Low
$186.280
Volume
0.47M
Company Fundamentals
Market Cap
3.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.23M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Oppenheimer Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $250
Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals with a Outperform and raises the price target from $190 to $250.
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025
JUPITER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. The company
Related Stocks
ARI
Apollo Commercial Real Estate Finance Inc
BBW
Build-A-Bear Workshop Inc.
EVM
Eaton Vance California Municipal Bond Fund Common Shares of Beneficial Interest $.01 par value
ABLLW
Abacus Life Inc. Warrant
PLPC
Preformed Line Products Company
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.